Skip to main content
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,396.80
-25.80 (-1.81%)
Apr 29, 2026, 3:30 PM IST

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 86.46B INR in the quarter ending December 31, 2025, with 8.36% growth. This brings the company's revenue in the last twelve months to 331.82B, up 7.31% year-over-year. In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B with 9.39% growth.

Revenue (ttm)
331.82B
Revenue Growth
+7.31%
P/S Ratio
2.44
Revenue / Employee
11.98M
Employees
27,707
Market Cap
811.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025317.24B27.22B9.39%
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Mankind Pharma 139.14B
Zydus Lifesciences 260.89B
Glenmark Pharmaceuticals 165.10B
Alkem Laboratories 142.53B
Cipla 279.67B
Laurus Labs 67.22B
Divi's Laboratories 103.14B
Ipca Laboratories 95.06B
Revenue Rankings

Aurobindo Pharma News

More News